Mice treated with Exendin-4-Fc showed significantly lower levels of postprandial glucose from days 1 to 5, as compared to the vehicle group
This is a preservation economy, not a performance boom
However, despite being the mainstay of CRC chemotherapy treatment, the primary anti-tumour mechanismsand more importantly, mechanisms facilitating 5FU resistance and persistenceremain poorly defined
This therapeutic approach may enhance cognitive benefits and neuroprotective effects by improving brain insulin signaling and glucose transport
Amato, A., Baldassano, S., Liotta, R., Serio, R
Hexarelin produces a more robust GH pulse but shows greater receptor desensitization over repeated exposures